These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37812884)
1. Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685. Qunies AM; Spitznagel BD; Du Y; David Weaver C; Emmitte KA Bioorg Med Chem; 2023 Nov; 95():117487. PubMed ID: 37812884 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies in a new series of 2-amino-N-phenylacetamide inhibitors of Slack potassium channels. Qunies AM; Mishra NM; Spitznagel BD; Du Y; Acuña VS; David Weaver C; Emmitte KA Bioorg Med Chem Lett; 2022 Nov; 76():129013. PubMed ID: 36184030 [TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationship Studies in a Series of Xanthine Inhibitors of SLACK Potassium Channels. Qunies AM; Spitznagel BD; Du Y; Peprah PK; Mohamed YK; Weaver CD; Emmitte KA Molecules; 2024 May; 29(11):. PubMed ID: 38893312 [TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. M Qunies A; A Emmitte K Pharm Pat Anal; 2022 Mar; 11(2):45-56. PubMed ID: 35369761 [TBL] [Abstract][Full Text] [Related]
6. The antipsychotic drug loxapine is an opener of the sodium-activated potassium channel slack (Slo2.2). Biton B; Sethuramanujam S; Picchione KE; Bhattacharjee A; Khessibi N; Chesney F; Lanneau C; Curet O; Avenet P J Pharmacol Exp Ther; 2012 Mar; 340(3):706-15. PubMed ID: 22171093 [TBL] [Abstract][Full Text] [Related]
7. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype. Evely KM; Pryce KD; Bhattacharjee A Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665 [TBL] [Abstract][Full Text] [Related]
8. Differential distribution of the sodium-activated potassium channels slick and slack in mouse brain. Rizzi S; Knaus HG; Schwarzer C J Comp Neurol; 2016 Jul; 524(10):2093-116. PubMed ID: 26587966 [TBL] [Abstract][Full Text] [Related]
9. cAMP-dependent kinase does not modulate the Slack sodium-activated potassium channel. Nuwer MO; Picchione KE; Bhattacharjee A Neuropharmacology; 2009 Sep; 57(3):219-26. PubMed ID: 19540251 [TBL] [Abstract][Full Text] [Related]
10. Impaired motor skill learning and altered seizure susceptibility in mice with loss or gain of function of the Kcnt1 gene encoding Slack (K Quraishi IH; Mercier MR; McClure H; Couture RL; Schwartz ML; Lukowski R; Ruth P; Kaczmarek LK Sci Rep; 2020 Feb; 10(1):3213. PubMed ID: 32081855 [TBL] [Abstract][Full Text] [Related]
11. Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy. Rizzo F; Ambrosino P; Guacci A; Chetta M; Marchese G; Rocco T; Soldovieri MV; Manocchio L; Mosca I; Casara G; Vecchi M; Taglialatela M; Coppola G; Weisz A Mol Cell Neurosci; 2016 Apr; 72():54-63. PubMed ID: 26784557 [TBL] [Abstract][Full Text] [Related]
12. An Epilepsy-Associated KCNT1 Mutation Enhances Excitability of Human iPSC-Derived Neurons by Increasing Slack K Quraishi IH; Stern S; Mangan KP; Zhang Y; Ali SR; Mercier MR; Marchetto MC; McLachlan MJ; Jones EM; Gage FH; Kaczmarek LK J Neurosci; 2019 Sep; 39(37):7438-7449. PubMed ID: 31350261 [TBL] [Abstract][Full Text] [Related]
19. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures. Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692 [TBL] [Abstract][Full Text] [Related]
20. Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1). Ali SR; Malone TJ; Zhang Y; Prechova M; Kaczmarek LK FASEB J; 2020 Jan; 34(1):1591-1601. PubMed ID: 31914597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]